Clinical Trial Update: PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update involving palbociclib in premenopausal women with ER-positive/HER2-negative metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Hamdy A. Azim | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN